IDH2 and neoplasm: IHC is a particularly convenient method of diagnosis for IDH mutations from a clinical perspective as the antibody can be applied and assessed alongside routine histological analysis often utilized to gain information about nuclear atypia, mitotic activity, microvascular proliferation, and necrosis within the tumor [201].